Evidence map›Paper›PMID 26877865›Full record

ArticleCell & bioscience2016

MiR-690, a Runx2-targeted miRNA, regulates osteogenic differentiation of C2C12 myogenic progenitor cells by targeting NF-kappaB p65.

Shouhe Yu, Qianqian Geng, Qiuhui Pan, Zhongyu Liu, Shan Ding, Qi Xiang, Fenyong Sun, Can Wang, Yadong Huang, An Hong

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The promising roles of macrophages in geriatric hip fracture.Frontiers in cell and developmental biology · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. MICROmanagement of Runx2 Function in Skeletal Cells.Current molecular biology reports · 2019
    Article
  14. Article
  15. Article
  16. microRNA Regulation of Skeletal Development.Current osteoporosis reports · 2017
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shouhe Yu *Institute of Biomedicine, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Bioengineering Medicine of Guangdong Province, Guangzhou, Guangdong People's Republic of China.
Qianqian Geng *Institute of Biomedicine, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Bioengineering Medicine of Guangdong Province, Guangzhou, Guangdong People's Republic of China.
Qiuhui Pan *Central Laboratory, People's 10th Hospital, Shanghai, People's Republic of China.
Zhongyu LiuCollege of Life Science, Yangtze University, Jingzhou, Hubei People's Republic of China.
Shan DingDepartment of Materials Science and Engineering, Jinan University, Engineering Research Center of Artificial Organs and Materials, Ministry of Education, Guangzhou, Guangdong People's Republic of China.
Qi XiangInstitute of Biomedicine, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Bioengineering Medicine of Guangdong Province, Guangzhou, Guangdong People's Republic of China.
Fenyong SunDepartment of Medical Laboratory, People's 10th Hospital, Shanghai, People's Republic of China.
Can WangCollege of Pharmacy, Jinan University, Guangzhou, Guangdong People's Republic of China.
Yadong HuangInstitute of Biomedicine, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Bioengineering Medicine of Guangdong Province, Guangzhou, Guangdong People's Republic of China.
An HongInstitute of Biomedicine, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Bioengineering Medicine of Guangdong Province, Guangzhou, Guangdong People's Republic of China.
Jinan University · CNYangtze University · CNShanghai Tenth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe runt-related transcription factor 2 (Runx2) is a cell-fate-determining factor that controls osteoblast differentiation and bone formation. It has been previously demonstrated that microRNAs (miRNAs) play important roles in osteogenesis. However, the Runx2-regulated miRNAs that have been reported thus far are limited. In this study, we pursued to identify these miRNAs in Tet-on stable C2C12 cell line (C2C12/Runx2(Dox) subline).

resultsMicroarray analysis revealed that alterations in miRNA expression occur with 54 miRNAs. Among these miRNAs, miR-690 was identified as a positive regulator of Runx2-induced osteogenic differentiation of C2C12 cells through gain- and loss-of-function assays. Expression of miR-690 is induced by Runx2, which binds directly to the putative promoter of mir-690 (Mirn690). The miR-690 proceeds to inhibit translation of the messenger RNA encoding the nuclear factor kappa B (NF-κB) subunit p65 whose overexpression inhibits Runx2-induced osteogenic differentiation of C2C12 cells. Interleukin-6 (IL-6), a downstream target of NF-κB pathway, is upregulated by p65 overexpression but significantly downregulated during this differentiation process. Furthermore, overexpression of IL-6 impedes the expression of osteocalcin, a defined marker of late osteoblast differentiation.

conclusionsTogether, our results suggest that the miR-690 transactivated by Runx2 acts as a positive regulator of Runx2-induced osteogenic differentiation by inactivating the NF-κB pathway via the downregulation of the subunit p65.

Indexed as

miR-690NF-κB pathwayOsteogenic differentiationp65Runx2

Identifiers

PMID26877865
PMCPMC4751671
OpenAlexW2261602831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.